Stay updated with breaking news from Regeneron Eylea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Friday, the FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) approved Eylea HD (aflibercept) Injection 8 mg for wet age-related macular degeneration, diabetic macular edema,
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 up 0.6% * Central banker commentary at Sintra panel in focus ...
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) June 28 (Reuters) - European shares climbed on Wednesday after robust U.S. data soothed concerns about a steep econom...
Industry watchers knew Roche’s Vabysmo would be a threat to Regeneron’s Eylea, but they didn’t foresee just how fast the new dual-action eye drug would grow.…